Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02943915 · ClinicalTrials.gov registry record · NA
The WISE Trial - Walking Improvement for SCI With Exoskeleton
A NA study of Injuries, Spinal Cord, sponsored by Ekso Bionics.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 10
- Study locations
NCT02943915: Completed NA study of Injuries, Spinal Cord, sponsored by Ekso Bionics.
NCT02943915 is a NA study of Injuries, Spinal Cord that has completed, run by Ekso Bionics. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02943915, a NA study of Injuries, Spinal Cord, has completed, sponsored by Ekso Bionics.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 10
- Study locations
Study Summary
A randomized, controlled trial comparing exoskeleton gait training with standard gait training or no gait training in community-dwelling participants with chronic incomplete spinal cord injury
Primary Outcome
The mean change in gait speed demonstrated during the 10MWT after 12 weeks of training and compared between groups. Positive values indicate improvement in gait speed (faster) from baseline to 12 weeks. Negative values indicate a reduction in gait speed (slower) from baseline to 12 weeks.
Conditions Studied
Interventions
- DEVICE Ekso GT Rehabilitation Therapy
- DEVICE Body Weight Supported (BWS) Treadmill Training
Study Locations (10)
Illinois
- Shirley Ryan AbilityLab - Chicago
- Marianjoy Rehabilitation Hospital - Wheaton
Arizona
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix
Connecticut
- Gaylord Hospital - Wallingford
Maryland
- Kennedy Kruger Institute - Baltimore
Michigan
- Rehabilitation Institute of Michigan - Detroit
Minnesota
- Courage Kenny Research Center - Minneapolis
New Jersey
- Kessler Foundation - West Orange
New York
- Burke Medical Research Institute - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-09-10 |
| Phase | NA |
What the finished NCT02943915 record still lists
NCT02943915 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Injuries, Spinal Cord appearing as the primary indexed condition, and to 2 interventions - of which Ekso GT Rehabilitation Therapy is the first listed.
NCT02943915 lists 10 locations in 9 states (Illinois, Arizona, Connecticut).
Frequently Asked Questions
What is clinical trial NCT02943915 about?
NCT02943915 is a clinical study titled "The WISE Trial - Walking Improvement for SCI With Exoskeleton". A randomized, controlled trial comparing exoskeleton gait training with standard gait training or no gait training in community-dwelling participants with chronic incomplete spinal cord injury
What is the current status of trial NCT02943915?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-09. Estimated completion is 2019-09-10.
What conditions does trial NCT02943915 study?
This clinical trial studies the following conditions: Injuries, Spinal Cord.
What interventions are being tested in trial NCT02943915?
The interventions under investigation include: Ekso GT Rehabilitation Therapy (DEVICE), Body Weight Supported (BWS) Treadmill Training (DEVICE).
Who is sponsoring clinical trial NCT02943915?
This trial is sponsored by Ekso Bionics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02943915 being conducted?
This trial has 10 study locations across Arizona, Connecticut, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Injuries, Spinal Cord
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02943915's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia